Paper Review Records
All Paper Review Records
24 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
43
days
Comparative bioavailability of a novel fixed‐dose combination of ticagrelor and acetylsalicylic acid
Authors
Susana Tera‐Ponce; Perla E. Castañeda‐Tera; Elva J. García‐Real; Francisco Ávila‐García; Kevin F. Rios‐Brito; Laura A. Lugo‐Sánchez; Daniel E. Sandoval‐Colin; Paola M. Medina‐Cárdenas; Jorge González‐CanudasShow moreShow less
Affiliations
1. Department of Pharmacology Faculty of Medicine National Autonomous University of Mexico (UNAM) Mexico City Mexico; 2. Unidad Clínica Farmacológica Bioemagno S. A. de C. V Mexico City Mexico; 3. Bioanalit Laboratorios S.A. de C.V Mexico City Mexico; 4. Research and Development Department Laboratorios Silanes S.A. de C.V. Mexico City Mexico; 5. Mexican Social Security Institute (IMSS) Centro Médico Nacional Siglo XXI Mexico City MexicoShow moreShow less
73
days
Pharmacokinetics and Bioequivalence of Tamsulosin Hydrochloride Extended‐Release Capsules in Healthy Chinese Volunteers: A Randomized, Open‐Label, Crossover Study Under Fasting and Fed Conditions
Authors
Lijie Du; Xiaolu Wang; Yi Zhang; Jiamin Yang; Fangliang Gan; Yaxun PangShow moreShow less
Affiliations
1. School of Pharmacy Hubei University of Science and Technology Xianning China; 2. Phase I Clinical Research Center Xianning Central Hospital The First Affiliated Hospital of Hubei University of Science and Technology Xianning China; 3. Department of Neurosurgery Xianning Central Hospital The First Affiliated Hospital of Hubei University of Science and Technology Xianning ChinaShow moreShow less
98
days
Pharmacokinetics and Bioequivalence Study of Levodopa and Benserazide Tablets in Healthy Chinese Subjects Under Fasting and High‐Fat Meal Conditions
Authors
Yufei Liang; Yanchao Wang; Rui Shi; Yingzi Pei; Xiao Zhao; Qian Wang; Yanping Ren; Zekang Xie; Kexin ZhaoShow moreShow less
Affiliations
1. Phase I Clinical Trials Center Hebei PetroChina Central Hospital Langfang China; 2. Department of Clinical Research Beijing Foyou Pharmaceutical Co., Ltd. Beijing ChinaShow moreShow less
119
days
Bioequivalence of Two Firsekibart Subcutaneous Formulations: A Randomized, Double‐Blind, Single‐Dose, Parallel‐Group Study in Healthy Chinese Participants
Authors
Yehua Xie; Xiao Li; Yushi Chen; Guangli Ma; Fei Gu; Yuling Lian; Xu Zhang; Xiaolan YongShow moreShow less
Affiliations
1. Changchun GeneScience Pharmaceutical Co., Ltd. Shanghai China; 2. Phase I Clinical Trial Center Chengdu Xinhua Hospital Chengdu ChinaShow moreShow less
152
days
Comparison of ABBV‐552 Safety and Pharmacokinetics in Healthy Asian and Western Adults
Authors
Nick Miles; Brian McNamee; Cindy Zadikoff; Joey Boiser; Mohamad Shebley; Ramesh BoinpallyShow moreShow less
Affiliations
1. Clinical Pharmacology AbbVie Inc. North Chicago IL USA; 2. Clinical Development Neuroscience AbbVie Inc. North Chicago IL USA; 3. Pharmacovigilance and Patient Safety AbbVie Inc. North Chicago IL USAShow moreShow less
56
days
A Phase 1 Study to Assess the Relative Bioavailability of Brigatinib Administered as an Oral Solution Versus an Immediate‐Release Tablet in Healthy Adults
Authors
Michael J. Hanley; Ronald Gounden; Bradley Hupf; Saurabh Sarkar; Robert J. Fram; Neeraj GuptaShow moreShow less
Affiliations
1. Takeda Development Center Americas, Inc. Cambridge MA USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days